Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

400 ARTÍCULOS , VIENDO DEL 61 AL 75

6-[18F]fluoro-L-DOPA: a well-established neurotracer with expanding application spectrum and strongly improved radiosyntheses

Pretze M, Wängler C, Wängler B.

Biomed Res Int. 2014;2014:674063. doi: 10.1155/2014/674063. Epub 2014 May 28.

Trueperella pyogenes infections in swine: clinical course and pathology

Jarosz ŁS, Gradzki Z, Kalinowski M.

Pol J Vet Sci. 2014;17(2):395-404. doi: 10.2478/pjvs-2014-0055.

Is ioflupane I123 injection diagnostically effective in patients with movement disorders and dementia? Pooled analysis of four clinical trials

O'Brien JT, Oertel WH, McKeith IG, Grosset DG, Walker Z, Tatsch K, Tolosa E, Sherwin PF, Grachev ID.

BMJ Open. 2014 Jul 3;4(7):e005122. doi: 10.1136/bmjopen-2014-005122.

Things that go bump in the night: diagnosing sleep-related movement disorders without a sleep laboratory

Reading P.

J R Coll Physicians Edinb. 2014;44(1):57-63. doi: 10.4997/JRCPE.2014.114.

Non-pharmacologic management of epilepsy

Parakh M, Katewa V.

Indian J Pediatr. 2014 Oct;81(10):1073-80. doi: 10.1007/s12098-014-1519-z. Epub 2014 Jul 5.

[Long acting injectable antipsychotics in the treatment of schizophrenia: a review of literature]

Graffino M, Montemagni C, Mingrone C, Rocca P.

Riv Psichiatr. 2014 May-Jun;49(3):115-23. doi: 10.1708/1551.16905.

Trifluoperazine versus low-potency first-generation antipsychotic drugs for schizophrenia

Tardy M, Dold M, Engel RR, Leucht S.

Cochrane Database Syst Rev. 2014 Jul 8;2014(7):CD009396. doi: 10.1002/14651858.CD009396.pub2.

Haloperidol versus low-potency first-generation antipsychotic drugs for schizophrenia

Tardy M, Huhn M, Kissling W, Engel RR, Leucht S.

Cochrane Database Syst Rev. 2014 Jul 9;2014(7):CD009268. doi: 10.1002/14651858.CD009268.pub2.

Clinical features and pharmacotherapy of childhood monoamine neurotransmitter disorders

Ng J, Heales SJ, Kurian MA.

Paediatr Drugs. 2014 Aug;16(4):275-91. doi: 10.1007/s40272-014-0079-z.

Deep brain stimulation for severe secondary stereotypies

Stocco A, Baizabal-Carvallo JF.

Parkinsonism Relat Disord. 2014 Sep;20(9):1035-6. doi: 10.1016/j.parkreldis.2014.06.019. Epub 2014 Jun 30.

Quantitative assessment based on kinematic measures of functional impairments during upper extremity movements: A review

de los Reyes-Guzmán A, Dimbwadyo-Terrer I, Trincado-Alonso F, Monasterio-Huelin F, Torricelli D, Gil-Agudo A.

Clin Biomech (Bristol). 2014 Aug;29(7):719-27. doi: 10.1016/j.clinbiomech.2014.06.013. Epub 2014 Jun 26.

Repetitive transcranial magnetic stimulation to treat depression and insomnia with chronic low back pain

Park EJ, Lee SJ, Koh DY, Han YM.

Korean J Pain. 2014 Jul;27(3):285-9. doi: 10.3344/kjp.2014.27.3.285. Epub 2014 Jun 30.

Evidence-based guidelines on the therapeutic use of repetitive transcranial magnetic stimulation (rTMS)

Lefaucheur JP, André-Obadia N, Antal A, Ayache SS, Baeken C, Benninger DH, Cantello RM, Cincotta M, de Carvalho M, De Ridder D, Devanne H, Di Lazzaro V, Filipović SR, Hummel FC, Jääskeläinen SK, Kimiskidis VK, Koch G, Langguth B, Nyffeler T, Oliviero A, Padberg F, Poulet E, Rossi S, Rossini PM, Rothwell JC, Schönfeldt-Lecuona C, Siebner HR, Slotema CW, Stagg CJ, Valls-Sole J, Ziemann U, Paulus W, Garcia-Larrea L.

Clin Neurophysiol. 2014 Nov;125(11):2150-2206. doi: 10.1016/j.clinph.2014.05.021. Epub 2014 Jun 5.

Anti-N-methyl-D-aspartate-receptor encephalitis: diagnosis, optimal management, and challenges

Mann AP, Grebenciucova E, Lukas RV.

Ther Clin Risk Manag. 2014 Jul 1;10:517-25. doi: 10.2147/TCRM.S61967. eCollection 2014.

Three phenotypes of anti-N-methyl-D-aspartate receptor antibody encephalitis in children: prevalence of symptoms and prognosis

DeSena AD, Greenberg BM, Graves D.

Pediatr Neurol. 2014 Oct;51(4):542-9. doi: 10.1016/j.pediatrneurol.2014.04.030. Epub 2014 May 29.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias